Skip to main content

Hexaminolevulinate use while Breastfeeding

Drugs containing Hexaminolevulinate: Cysview

Medically reviewed by Drugs.com. Last updated on Mar 11, 2021.

Hexaminolevulinate Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the clinical use of hexaminolevulinate during breastfeeding. After instillation into the bladder, only about 7% of a dose is absorbed into the maternal bloodstream, so the amount of drug excreted into milk is expected to be minimal. Until more data become available, hexaminolevulinate should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Hexaminolevulinate

CAS Registry Number

140898-97-1

Drug Class

  • Breast Feeding
  • Lactation
  • Diagnostic Agents
  • Photosensitizing Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

More about hexaminolevulinate

Consumer resources

Other brands
Cysview

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.